BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Stem cell
,
Amniocentesis
,
Acetaminophen
,
rs2300478
,
PTEN
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antigen receptor T cells
Summary
General Info
Curated Studies
Most Correlated Studies
Regulatory T (Treg) cells and conventional T cells reponses to different factors and conditions
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
CD4 T-cells with MTOR, ZAP70 silencing, or treated with Rapamycin or Cyclosporin A
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Contrastive learning of T cell receptor representations.
Modifications to rhesus macaque TCR constant regions improve TCR cell surface expression.
T-switch-ing TCR specificity.
Enhanced T cell receptor specificity through framework engineering.
Parsing digital or analog TCR performance through piconewton forces.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma
Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma
Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T C…
Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma T…
Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gl…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ